Curanex Pharmaceuticals (NASDAQ:CURX) Releases Earnings Results

Curanex Pharmaceuticals (NASDAQ:CURX) announced its quarterly earnings results on Monday. The company reported ($0.12) earnings per share (EPS) for the quarter, Zacks reports.

Curanex Pharmaceuticals Trading Up 4.8%

Shares of Curanex Pharmaceuticals stock opened at $0.51 on Wednesday. The firm has a market capitalization of $14.49 million and a P/E ratio of -3.01. The business has a fifty day simple moving average of $0.38 and a two-hundred day simple moving average of $0.62. Curanex Pharmaceuticals has a 12 month low of $0.26 and a 12 month high of $9.18.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Curanex Pharmaceuticals stock. Citadel Advisors LLC purchased a new stake in shares of Curanex Pharmaceuticals Inc (NASDAQ:CURX) in the third quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 64,067 shares of the company’s stock, valued at approximately $46,000.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reaffirmed a “sell (e-)” rating on shares of Curanex Pharmaceuticals in a research report on Monday, December 29th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Curanex Pharmaceuticals currently has an average rating of “Sell”.

About Curanex Pharmaceuticals

Curanex is a developmental stage pharmaceutical company dedicated to discovering, developing and commercializing innovative botanical drugs to treat patients suffering from inflammatory diseases. Our mission is to address significant unmet medical needs and improve patients’ lives by harnessing the power of natural substances. We are dedicated to discovering, developing and commercializing botanical medicines for treating patients with immune and inflammatory diseases and to develop therapies that may offer potential benefits to patients with unmet clinical needs in various fields, such as autoimmune diseases, metabolic diseases and viral infections.